Document Type

Article

Publication Date

5-1-2016

Comments

This article has been peer reviewed. It was published in: Current Stem Cell Research and Therapy.

Volume 11, Issue 4, 1 May 2016, Pages 321-328.

The published version is available at DOI: 10.2174/1574888X10666150723150059

Copyright © 2016, Bentham Science Publishers

Abstract

A large body of work has been published on transplantation of a wide range of neural stem and progenitor cell types derived from the developing and adult CNS, as well as from pluripotent embryonic stem cells, in models of traumatic spinal cord injury (SCI). However, many of these cell-based approaches present practical issues for clinical translation such as ethical cell derivation, generation of potentially large numbers of homogenously prepared cells, and immune rejection. With the advent of induced Pluripotent Stem (iPS) cell technology, many of these issues may potentially be overcome. To date, a number of studies have demonstrated integration, differentiation into mature CNS lineages, migration and long-term safety of iPS cell transplants in a variety of SCI models, as well as therapeutic benefits in some cases. Given the clinical potential of this advance in stem cell biology, we present a concise review of studies published to date involving iPS cell transplantation in animal models of SCI.

PubMed ID

26201863

Download

Share

COinS